An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection is a research paper published in Journal of Clinical Investigation (2020). On theSindex it has a DataRank of 0.538. It has been cited 35 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.538
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Neag Cancer Immunology Translational Program
Grant: N/A
US National Institutes of Health
Grant: R35GM118166
NCI NIH HHS
Grant: P30 CA008748
National Institutes of Health
Grant: 5R35GM118166-04
Structural biophysics and molecular design in cellular immunity
FWCI
1.36
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals